These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
170 related items for PubMed ID: 24759835
1. Correlation of microRNA-16, microRNA-21 and microRNA-101 expression with cyclooxygenase-2 expression and angiogenic factors in cirrhotic and noncirrhotic human hepatocellular carcinoma. Zeng W, van den Berg A, Huitema S, Gouw AS, Molema G, de Jong KP. PLoS One; 2014; 9(4):e95826. PubMed ID: 24759835 [Abstract] [Full Text] [Related]
3. The angiogenic makeup of human hepatocellular carcinoma does not favor vascular endothelial growth factor/angiopoietin-driven sprouting neovascularization. Zeng W, Gouw AS, van den Heuvel MC, Zwiers PJ, Zondervan PE, Poppema S, Zhang N, Platteel I, de Jong KP, Molema G. Hepatology; 2008 Nov; 48(5):1517-27. PubMed ID: 18924243 [Abstract] [Full Text] [Related]
4. Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival. Jiang J, Gusev Y, Aderca I, Mettler TA, Nagorney DM, Brackett DJ, Roberts LR, Schmittgen TD. Clin Cancer Res; 2008 Jan 15; 14(2):419-27. PubMed ID: 18223217 [Abstract] [Full Text] [Related]
6. MicroRNA signature in patients with hepatocellular carcinoma associated with type 2 diabetes. Elemeery MN, Mohamed MA, Madkour MA, Shamseya MM, Issa NM, Badr AN, Ghareeb DA, Pan CH. World J Gastroenterol; 2019 Nov 14; 25(42):6322-6341. PubMed ID: 31754293 [Abstract] [Full Text] [Related]
11. Next generation sequencing reveals microRNA isoforms in liver cirrhosis and hepatocellular carcinoma. Wojcicka A, Swierniak M, Kornasiewicz O, Gierlikowski W, Maciag M, Kolanowska M, Kotlarek M, Gornicka B, Koperski L, Niewinski G, Krawczyk M, Jazdzewski K. Int J Biochem Cell Biol; 2014 Aug 14; 53():208-17. PubMed ID: 24875649 [Abstract] [Full Text] [Related]
15. MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma. Fang F, Chang RM, Yu L, Lei X, Xiao S, Yang H, Yang LY. J Hepatol; 2015 Oct 14; 63(4):874-85. PubMed ID: 25998163 [Abstract] [Full Text] [Related]
16. Cyclooxygenase-2 and vascular endothelial growth factor in chronic hepatitis, cirrhosis and hepatocellular carcinoma. Kwon SH, Jeong SW, Jang JY, Lee JE, Lee SH, Kim SG, Kim YS, Cho YD, Kim HS, Kim BS, Jin SY. Clin Mol Hepatol; 2012 Sep 14; 18(3):287-94. PubMed ID: 23091809 [Abstract] [Full Text] [Related]
19. Serum microRNA let-7a-1/let-7d/let-7f and miRNA 143/145 Gene Expression Profiles as Potential Biomarkers in HCV Induced Hepatocellular Carcinoma. Aly DM, Gohar NA, Abd El-Hady AA, Khairy M, Abdullatif MM. Asian Pac J Cancer Prev; 2020 Feb 01; 21(2):555-562. PubMed ID: 32102538 [Abstract] [Full Text] [Related]